Clinical Trial Update: Vascular Inflammation and Cholesterol Lowering Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examining vascular inflammation and cholesterol-lowering therapy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipid Lowering
• Vascular Inflammation

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Lipid Lowering, Vascular Inflammation | Phase 4 | Status: WITHDRAWN